发明申请
- 专利标题： Hydroxyalkyl Substituted Imidazonaphthyridines
- 专利标题（中）： 羟烷基取代的咪唑并萘啶
-
申请号： US11885007申请日： 2006-02-22
-
公开(公告)号： US20090253695A1公开(公告)日： 2009-10-08
- 发明人: Tushar A. Kshirsagar , Scott E. Langer , Shri Niwas , George W. Griesgraber , Philip D. Heppner , Kyle J. Lindstrom
- 申请人： Tushar A. Kshirsagar , Scott E. Langer , Shri Niwas , George W. Griesgraber , Philip D. Heppner , Kyle J. Lindstrom
- 申请人地址： US MA Wellesley
- 专利权人： Coley Pharmaceutical Group, Inc,
- 当前专利权人： Coley Pharmaceutical Group, Inc,
- 当前专利权人地址： US MA Wellesley
- 国际申请： PCT/US06/06043 WO 20060222
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D471/14 ; A61K31/4375 ; A61K31/497
摘要：
Certain imidazonaphthyridines with a hydroxymethyl or hydroxyethyl substituent at the 2-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for preferentially inducing IFN-α biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
公开/授权文献
- US08343993B2 Hydroxyalkyl substituted imidazonaphthyridines 公开/授权日：2013-01-01
信息查询
IPC分类:
